ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.7181
0.00%
Brent Oil
79.285
0.00%
Bitcoin
94,229.60
-0.50%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. RAPT Therapeutics Inc (RAPT) Cotización

RAPT Therapeutics Inc

RAPT Therapeutics Inc (RAPT)

NASDAQ
1.32
-0.13
(-8.97%)
Cerrado 11 Enero 3:00PM
Delayed by 15 minutes
1.3199
-0.0001
(-0.01%)
Fuera de horario: 6:39PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
1.3199
Postura de Compra
1.25
Postura de Venta
1.32
Volume Operado de la Acción
2,379,488
1.27 Rango del Día 1.44
0.78925 Rango de 52 semanas 27.35
Capitalización de Mercado [m]
46.141M
Precio Anterior
1.45
Precio de Apertura
1.40
Hora
40
@
1.29
Última hora de negociación
Volumen financiero
US$ 3,218,038
Precio Promedio Ponderado
1.3524
Volumen promedio (3 m)
3,575,965
Acciones en circulación
34,958,253
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.39
Beneficio por acción (BPA)
-3.34
turnover
-
Beneficio neto
-116.8M

Acerca de RAPT Therapeutics Inc

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX... RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.rapt.com
Sede
Dover, Delaware, USA
Fundado
-
RAPT Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RAPT. The last closing price for RAPT Therapeutics was US$1.45. Over the last year, RAPT Therapeutics shares have traded in a share price range of US$ 0.78925 to US$ 27.35.

RAPT Therapeutics currently has 34,958,253 shares in issue. The market capitalisation of RAPT Therapeutics is US$50.69 million. RAPT Therapeutics has a price to earnings ratio (PE ratio) of -0.39.

RAPT Últimas noticias

Más noticias

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering...

09 Enero 2025
GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

06 Enero 2025
Edgar (US Regulatory)

Form 8-K - Current report

06 Enero 2025
Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

06 Enero 2025
Edgar (US Regulatory)

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering...

06 Enero 2025
GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities

03 Enero 2025
Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

30 Diciembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

23 Diciembre 2024
Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

23 Diciembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

23 Diciembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.3501-20.96407185631.671.7791.2810797091.62001036CS
40.320132.01640328070.99982.320.78925101361681.72008913CS
12-0.3801-22.35882352941.73.320.7892535759651.71000541CS
26-1.8901-58.88161993773.213.8250.7892517358261.78149333CS
52-23.4801-94.677822580624.827.350.7892513796834.39024845CS
156-37.0201-96.55738132538.3438.340.789256987019.81257659CS
260-26.4801-95.252158273427.851.20950.7892554059714.58298164CS

RAPT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de RAPT Therapeutics?
El precio actual de las acciones de RAPT Therapeutics es US$ 1.3199
¿Cuántas acciones de RAPT Therapeutics están en circulación?
RAPT Therapeutics tiene 34,958,253 acciones en circulación
¿Cuál es la capitalización de mercado de RAPT Therapeutics?
La capitalización de mercado de RAPT Therapeutics es USD 50.69M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de RAPT Therapeutics?
RAPT Therapeutics ha negociado en un rango de US$ 0.78925 a US$ 27.35 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de RAPT Therapeutics?
El ratio precio/beneficio de RAPT Therapeutics es -0.39
¿Cuál es la moneda de reporte de RAPT Therapeutics?
RAPT Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de RAPT Therapeutics?
El último beneficio anual de RAPT Therapeutics es USD -116.8M
¿Cuál es la dirección registrada de RAPT Therapeutics?
La dirección registrada de RAPT Therapeutics es 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
¿Cuál es la dirección del sitio web de RAPT Therapeutics?
La dirección del sitio web de RAPT Therapeutics es www.rapt.com
¿En qué sector industrial opera RAPT Therapeutics?
RAPT Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

RAPT Discussion

Ver más
Monksdream Monksdream 7 días hace
RAPT, under $2
👍️0
tbonaces80 tbonaces80 2 semanas hace
Buy this. Smart money in. 
👍️0
tbonaces80 tbonaces80 2 semanas hace
Gonna breakout above $2.11. Hold for major move. Shares gobbled on this wedge
👍️0
glenn1919 glenn1919 2 semanas hace
RAPT......................https://stockcharts.com/h-sc/ui?s=RAPT&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 semanas hace
$2.20 + 20%
👍️0
tbonaces80 tbonaces80 2 semanas hace
Wainwright ups price to $10. This will be going parabolic 
👍️0
tbonaces80 tbonaces80 2 semanas hace
We go hard this week. Too many Capital firms bought in. Load the boat $6-$10 easy
👍️0
tbonaces80 tbonaces80 2 semanas hace
This will hit $6 easily. Analysts know. Huge funding.  Foully loaded. 
👍️0
PonkenPlonken PonkenPlonken 2 semanas hace
@tbonaces80 @Princess17
What do you two think about this?
150 million pp says massively misunderstood story? 140mn historical volume too...
👍️0
tbonaces80 tbonaces80 3 semanas hace


👍️0
tbonaces80 tbonaces80 3 semanas hace
Load zone. 
👍️0
Princess17 Princess17 3 semanas hace
👍🏻 looks good 
👍️0
tbonaces80 tbonaces80 3 semanas hace
Upgrade. Wells. Yup 
👍️0
PonkenPlonken PonkenPlonken 3 semanas hace
see chart and compare PP to market cap
must be massively misunderstood

also had a license agreement today
Regards
👍️0
bigbux1 bigbux1 3 semanas hace
What am I missing? They just did a private placement of 100,000,000 shares of common stock at a purchase price of $0.85 per share and this soars past 1.50?
👍️0
Mister Mr Mister Mr 3 semanas hace
Keep pumping! Let's go!!!
👍️0
glenn1919 glenn1919 3 semanas hace
rapt........................https://stockcharts.com/h-sc/ui?s=rapt&p=W&b=5&g=0&id=p86431144783
👍️0
PonkenPlonken PonkenPlonken 3 semanas hace
https://www.globenewswire.com/news-release/2024/12/23/3001133/0/en/RAPT-Therapeutics-Announces-150-Million-Private-Placement.html
wow!
market cap 30 million no discount
👍️0
Invest-in-America Invest-in-America 3 semanas hace
RAPT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175569055
👍️0
tw0122 tw0122 3 semanas hace
RAPT up 15% news and TRAW also up $13.77 + 150% TRAW up big
👍️0
glenn1919 glenn1919 1 mes hace
RAPT.........................https://stockcharts.com/h-sc/ui?s=RAPT&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 meses hace
RAPT under $3
👍️0
Monksdream Monksdream 4 meses hace
RAPT new 52 week low
👍️0
Monksdream Monksdream 5 meses hace
RAPT new 52 low
👍️0
Monksdream Monksdream 6 meses hace
RAPT under $4
👍️0
Monksdream Monksdream 8 meses hace
RAPT new 52 week
👍️0
Monksdream Monksdream 8 meses hace
RAPT under $10
👍️0
tickersym tickersym 11 meses hace
Bargin prices!! Lets go!!
👍️0
Stockexpertpro Stockexpertpro 11 meses hace
RAPT Only 1 Patient had a problem out of 350 people enrolled in the trial

https://finance.yahoo.com/news/1-fda-puts-hold-two-125809258.html Fire sale down here lots of upgrades out last weeK
👍️0
StockLogistics StockLogistics 2 años hace
Surprised that no gap fill occurred prior to results expected near September 12, showing major strength buoyed by estimates of 50.00:

“8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced it has initiated its 16-week randomized, double-blind, placebo-controlled Phase 2b clinical trial to further evaluate the efficacy and safety of RPT193 as monotherapy in patients with moderate-to-severe atopic dermatitis (AD).”
👍️0
StockLogistics StockLogistics 3 años hace
12.16 gap fill over the next 14.5 weeks
👍️0
StockLogistics StockLogistics 3 años hace
12.16 gap fill over the next 14.5 weeks
👍️0
StockLogistics StockLogistics 3 años hace
15 weeks to go

8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

Countdown to potential billions in revenue.
👍️0
StockLogistics StockLogistics 3 años hace
A ton of insider buying last week
👍️0
StockLogistics StockLogistics 3 años hace
Positive sentiment about billions that could be made from Rapt’s drug and pipe financing, perfect storm brewing
👍️0
Glider549 Glider549 4 años hace
It happens,,and more often than not doesn't.
That's why I'd trim, but leave some on the table.
👍️0
weasel4339 weasel4339 4 años hace
It's way up after hours bud
👍️0
Glider549 Glider549 4 años hace
Can't believe some of you did not take profits near the close.
Greed will kill ya.
👍️0
pennyfinder pennyfinder 4 años hace
Will do
👍️0
weasel4339 weasel4339 4 años hace
I'll keep n eye out. Let me knoe if u hear something about the price
👍️0
pennyfinder pennyfinder 4 años hace
Supposed to be. There’s no price set on the offering. They just said they’re raising $125M, they could be raising at $50… who knows… but the history has always been lower than the closing price. We will have to wait and see.
👍️0
weasel4339 weasel4339 4 años hace
This considered dilution?
👍️0
pennyfinder pennyfinder 4 años hace
LOL

https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-announces-proposed-public-offering-common
👍️0
make it happen make it happen 4 años hace
Most def. Idk how these companies even give a PT like that. Happens way to often and retails get blindsided. I wouldn't even do that if had all the power too.
👍️0
pennyfinder pennyfinder 4 años hace
Offering AH or tomorrow pre
👍️0
make it happen make it happen 4 años hace
Negative 1,000% plus operating margins. Only Phase 1 still, A long way to go...

Large negative lose percentages across the board on margins.

Only $0.22 revenue per share

Cash flow will burn all money before end of year.

Profitability
Profit Margin 0.00%
Operating Margin (ttm) -1,064.70%

Management Effectiveness
Return on Assets (ttm) -27.62%
Return on Equity (ttm) -50.34%

Income Statement
Revenue (ttm) 5.33M
Revenue Per Share (ttm) 0.22
Quarterly Revenue Growth (yoy) 30.70%
Gross Profit (ttm) 5.04M
EBITDA -55.53M
Net Income Avi to Common (ttm) -56.27M
Diluted EPS (ttm) -2.29

Balance Sheet
Total Cash (mrq) 98.41M
Total Cash Per Share (mrq) 3.93
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 9.21
Book Value Per Share (mrq) 3.69

Cash Flow Statement
Operating Cash Flow (ttm) -45.66M
Levered Free Cash Flow (ttm) -23.3M
👍️0
StockLogistics StockLogistics 4 años hace
This stock reported legitimate results of its study and is a short squeeze candidate imo if Reddit wanted to wake up to it
👍️0
Roadtojourney Roadtojourney 5 años hace
Not even 6 months old and already offering??
👍️0
crudeoil24 crudeoil24 5 años hace
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It is developing selective small molecules designed to modulate the critical immune responses underlying these diseases. It has discovered and advanced two drug candidates FLX475 and RPT193, which is engaged in targeting C-C motif chemokine receptor 4 (CCR4). Its drug discovery and development engine has identified CCR4 as a drug target that potentially has broad applicability in oncology and inflammatory diseases. Its lead oncology drug candidate FLX475, is designed to selectively inhibit the migration of immunosuppressive regulatory Treg cells into tumors. Its RPT193 drug candidate, is designed to selectively inhibit the migration of type 2 T helper cells (Th2 cells), into allergically-inflamed tissues.
👍️0
crudeoil24 crudeoil24 5 años hace
42.00 > hod.

RAPT
👍️0

Su Consulta Reciente

NASDAQ
RAPT
RAPT Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados